Interleukin-2 lymphokine-activated killer cell therapy of non-Hodgkin's lymphoma and Hodgkin's disease. (Record no. 2049775)

MARC details
000 -LEADER
fixed length control field 01470 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250511220817.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199107s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1053-8550
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1097/00002371-199104000-00008
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Bernstein, Z P
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19910715
245 00 - TITLE STATEMENT
Title Interleukin-2 lymphokine-activated killer cell therapy of non-Hodgkin's lymphoma and Hodgkin's disease.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of immunotherapy : official journal of the Society for Biological Therapy
Date of publication, distribution, etc. Apr 1991
300 ## - PHYSICAL DESCRIPTION
Extent 141-6 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Evaluation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hodgkin Disease
General subdivision therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunotherapy, Adoptive
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interleukin-2
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Killer Cells, Lymphokine-Activated
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphoma, Non-Hodgkin
General subdivision therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vaickus, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Friedman, N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Goldrosen, M H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Watanabe, H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rahman, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Arbuck, S G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sweeney, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vesper, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Henderson, E D
773 0# - HOST ITEM ENTRY
Title Journal of immunotherapy : official journal of the Society for Biological Therapy
Related parts vol. 10
-- no. 2
-- p. 141-6
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1097/00002371-199104000-00008">https://doi.org/10.1097/00002371-199104000-00008</a>
Public note Available from publisher's website

No items available.